33 studies found for:    Open Studies | "Kidney Diseases, Cystic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
2 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
3 Recruiting New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
4 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
5 Recruiting Pasireotide LAR in Severe Polycystic Liver Disease
Conditions: Somatostatin Analogs;   Polycystic Liver Disease;   Autosomal Dominant Polycystic Kidney Disease;   Autosomal Dominant Polycystic Liver Disease
Interventions: Drug: Pasireotide LAR;   Drug: Placebo
6 Recruiting Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
Conditions: Polycystic Liver Disease (PLD):;   Polycystic Kidney, Autosomal Dominant;   Polycystic Liver Disease
Intervention: Drug: Ursodeoxycholic Acid
7 Recruiting Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
Condition: ADPKD
Intervention:
8 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
9 Recruiting Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Triptolide-Containing Formulation;   Drug: Placebo
10 Recruiting Clinical Implications of DNA Analysis on ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
11 Unknown  Clinical Trial to Slow the Progression of ADPKD
Conditions: Kidney, Polycystic;   Kidney, Polycystic, Autosomal Dominant
Intervention: Drug: anti-hypertensive medications
12 Recruiting Dismembered Pyeloplasty With and Without After Coming Stent
Conditions: Pelviureteric Junction Obstruction;   Pyeloplasty;   Neonate Affected by Hydronephrosis;   Obstructive Uropathy;   Urinary Stent
Interventions: Procedure: After coming stent after dismembered pyeloplasty;   Procedure: Stentless dismembered pyeloplasty
13 Recruiting Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Intervention: Dietary Supplement: Niacinamide
14 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
15 Unknown  Everolimus on CKD Progression in ADPKD Patients
Condition: Polycystic Kidney Diseases
Interventions: Drug: Everolimus;   Drug: Standard Therapy
16 Unknown  Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Cilnidipine;   Drug: Imidapril
17 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
18 Recruiting Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
19 Recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
20 Recruiting The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Indicates status has not been verified in more than two years